Company Filing History:
Years Active: 2016
Title: Friedrich Michael Haller: Innovating in Hemostasis
Introduction
Friedrich Michael Haller is an accomplished inventor based in Norman, Oklahoma, who has made significant contributions to the field of biochemistry, particularly in the area of coagulation factors. With a keen focus on improving therapeutic outcomes for patients with bleeding disorders, Haller holds one patent that highlights his innovative approach in this field.
Latest Patents
Haller's most notable patent, titled "Coagulation factor VII polypeptides," relates to modified coagulation Factor VII polypeptides. This invention entails polypeptides that demonstrate increased resistance to antithrombin inactivation and enhanced proteolytic activity. The patent encompasses polynucleotide constructs encoding the polypeptides, vectors, and host cells that express these polynucleotides, along with potential pharmaceutical compositions, uses, and methods of treatment.
Career Highlights
Friedrich is associated with Novo Nordisk Healthcare AG, a leading global healthcare company known for its focus on diabetes care and other chronic conditions. His work contributes to the innovation of treatments that significantly improve patient quality of life. His research endeavors reflect his commitment to advancing medical science through rigorous investigation and inventive solutions.
Collaborations
Throughout his career, Haller has collaborated with esteemed colleagues, including Henrik Oestergaard and Prafull S. Gandhi. These collaborations highlight a shared vision of enhancing healthcare outcomes through innovative biopharmaceutical solutions. Working together, they push the boundaries of current knowledge and practice in the field of coagulation studies.
Conclusion
Friedrich Michael Haller’s contributions to the medical field through his innovative inventions underscore the transformative power of research and development in addressing critical health challenges. His work with coagulation factors exemplifies how targeted inventions can pave the way for advanced therapeutic methods and improved patient care. Haller's endeavors reflect not only his individual genius but also the collaborative spirit that drives innovation within the healthcare industry.